Complications of hepatitis C: Symptoms and when to see a doctor
Hepatitis C is a viral infection that causes inflammation of the liver. If left without treatment, it can cause complications, such as scarring and long term liver damage, which increases the risk of liver cancer.
A recent article from Medical News Today discusses Hepatitis C, symptoms and more.
Hepatitis C, or HCV, is a viral infection that causes inflammation of the liver. Over time, this can result in permanent liver damage and other health complications. Find out more about the complications of HCV here.
The Stages of Liver Disease - American Liver Foundation
Understanding the different stages and progression of liver disease can be difficult.
A helpful resource from the American Liver Foundation gives some insight into the progression of liver disease, some definitions, and what each stage means.
Cirrhosis, cancer and liver failure stages can threaten your life. It’s important to catch liver disease early, in the inflammation and fibrosis stages.
Fatty liver disease: An often-silent condition linked to heart disease - Harvard Health
A recent article from Harvard Health Publishing discusses NAFLD, possible links to heart disease, and more. The article covers diagnosis and possible treatments.
As many as one in four Americans has a potentially dangerous accumulation of fat in the liver. Known as nonalcoholic fatty liver disease, it is closely linked to obesity and diabetes and may boost heart disease risk. The milder form of the disease, n…
Nonalcoholic fatty liver disease: New drug proves 'safe and effective'
Researchers in Austria are examining a new treatment for NAFLD.
Scientists are studying nor-urso, a modified version of ursodeoxycholic acid, a common oral drug that can alter the makeup of bile and may dissolve gallstones. The study authors stated, “In conclusion, a 1,500-mg dosage of nor-urso “resulted in a significant reduction of serum ALT within 12 weeks of treatment, when compared with placebo.”
The findings have been published in The Lancet Gastroenterology & Hepatology.
A double-blind, placebo-controlled randomized clinical trial finds the right dosage at which a drug ‘safely’ treats nonalcoholic fatty liver disease.
Today is World Hepatitis Day. Taking action and raise awareness.
Today is World Hepatitis Day. This day is for taking action and raise awareness to help find the millions of undiagnosed individuals with hepatitis.
According to the World Hepatitis Alliance: 🔬 300 million people worldwide are living with viral hepatitis and are unaware they have it. 🔬 Viral hepatitis causes up to 1.34 million deaths per year. 🔬 A cure for hepatitis C and treatment and a vaccine for hepatitis B exists.
Weight loss may lead to significant improvements in patients with NAFLD
Recent research shows that weight loss may lead to significant short and medium-term improvements in patients with NAFLD.
The findings have been published in JAMA Internal Medicine.
NASH liver disease progression in 3D: from healthy liver to cirrhosis
Have you ever wondered what is happening in your liver? A short video from The NASH Education Program discusses disease progression from NAFL to NASH.
Non-alcoholic steatohepatitis (NASH) is the most serious form of non-alcoholic fatty liver disease (NAFLD). NASH is defined by the presence of the 3 following…
Is nonalcoholic steatohepatitis (NASH) a "hidden epidemic"?
Liver health advocates are declaring nonalcoholic steatohepatitis (NASH) to be a “hidden epidemic.”
A recent article from Healio discusses the importance of increasing awareness, and ways in which advocacy groups are hoping to do so.
Is your liver at risk? - Harvard Health
Did you know that an estimated 64 million Americans have nonalcoholic fatty liver disease (NAFLD)?
A recent article from Harvard Health Publishing discusses NAFLD, risk factors, and some possible treatments.
Nonalcoholic fatty liver disease is a common condition that can lead to serious problems. Risk factors for the condition include obesity, diabetes., high blood pressure, and high cholesterol. While many Americans have the condition, it can be reverse…
Today is International NASH Day
Today is International NASH Day. This day is dedicated to raising awareness of nonalcoholic steatohepatitis, or NASH, and promoting early intervention.
According to the The NASH Education Program:
💊 NASH is present in approximately 1.5-6.45% of the global population. 💊 NAFLD affects more than 25% of the world’s population.
Share to help spread awareness of this incredible important day!
Even Moderate Exercise May Cut Risk for Liver-Related Death
Research recently presented at Digestive Disease Week in San Diego shows that moderate exercise can help to reduce the risk of liver-related death.
Greatest benefit observed in those who paired walking with strength training
Study finds link between herbicide and human liver disease
Recent research shows a possible link between glyphosate (a primary component in weed killer), and liver disease. Scientists urge that more research is needed to understand the possible connection.
Glyphosate, the primary ingredient in Monsanto’s popular weed killer Roundup, has been linked to liver disease in animal models.
More young adults developing serious liver disease caused by heavy drinking
A recent article from NBC News discusses the findings from a study showing that alcohol-related liver disease is on the rise, and in young adults.
Experts say the increase may be due to heavy binge drinking, especially in young adults.
Liver fibrosis: Stages, symptoms, and treatment
Liver fibrosis happens when repetitive or long-lasting injury or inflammation leads to the excessive buildup of scar tissue in the liver.
A recent article from Medical News Today discusses liver fibrosis, its stages, symptoms, treatments, and more.
Liver fibrosis occurs when chronic injury or inflammation causes a buildup of scar tissue. This interferes with the liver’s ability to function and regenerate. In this article, we look at how liver fibrosis develops and when treatment can reverse the damage.